RINVOQ
RINVOQ
Approved
DIN Number
02539721
Drug Class
Human
Market Date
Sep 7, 2023
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02539721
AIG Number0162012003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AF03 UPADACITINIB
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification90:24.12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
UPADACITINIBActive
Strength: 45 MG
Monograph: UPADACITINIB